Work

Efficacy and safety of zanubrutinib, rituximab, and venetoclax combination regimen in previously untreated follicular lymphoma: A Phase II trial from the bbc study

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417009167
Cites:
Cited by:
Related to: